Autism spectrum disorders (ASD) reflect a critical gap in medical care, often involving challenges in social communication, with limited treatments available for core symptoms. A key barrier to ...
In another important milestone, PeriVision has signed a clinical trial agreement with Genentech, Roche's US business unit. The aim is to evaluate the potential use of the VisionOne platform in ...
Mabylon AG is a Schlieren-based biotechnology company at the forefront of human-derived antibody research, with a primary focus on allergies, neurological and inflammatory disorders. The company has ...
Actival, a spin-off from CSEM in Neuchâtel, is launching transparent 3D-printed aligners equipped with microchannels that release an antibacterial fluid, ensuring precise tooth alignment while ...
Die 2022 gegründete FlexBase Group will in Laufenburg ein Technologiezentrum aufbauen. Das Zentrum umfasst eine der bisher global grössten realisierten Speicherbatterien sowie ein KI-Rechencenter. Der ...